CompletedNot Applicable

Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists.

Germany461 participantsStarted 2014-09

Plain-language summary

The purpose of this study is to detect factors influencing decision making for treatment pathways of hormone-naïve prostate cancer patients with and without comorbidities receiving medicinal androgen deprivation therapy (Degarelix or LHRH agonists).

Who can participate

Sex

MALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed with Prostate Cancer and indicated for ADT according to Summary of Product Characteristics (SmPC) * Decision made to prescribe ADT (Degarelix or LHRH agonist) prior to enrolment Exclusion Criteria: * Patient had previous or is currently under hormonal management of Prostate Cancer, except for a curative intention, where the duration of the neoadjuvant/adjuvant therapy did not exceed 6 months and treatment should have been terminated at least 6 months prior to baseline. * Participation in a clinical trial at baseline and during the follow-up period

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Level of urologist's knowledge of patients' medical history at the point of decision making and during Androgen Deprivation Therapy (ADT)

Timeframe: Up to 4 years

Level of urologist's knowledge of patients' comorbidities at the point of decision making and during ADT

Timeframe: Up to 4 years

Level of urologist's knowledge of patients' concomitant medications at the point of decision making and during ADT

Timeframe: Up to 4 years

Level of urologist's knowledge of patients' risk factors at the point of decision making and during ADT

Timeframe: Up to 4 years

Trial details

NCT IDNCT02234089

SponsorFerring Pharmaceuticals

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2019-06-30

View on ClinicalTrials.gov More Advanced Prostate Cancer trials

Who can participate

Sex

MALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Level of urologist's knowledge of patients' medical history at the point of decision making and during Androgen Deprivation Therapy (ADT)

Timeframe: Up to 4 years

Level of urologist's knowledge of patients' comorbidities at the point of decision making and during ADT

Timeframe: Up to 4 years

Level of urologist's knowledge of patients' concomitant medications at the point of decision making and during ADT

Timeframe: Up to 4 years

Level of urologist's knowledge of patients' risk factors at the point of decision making and during ADT

Timeframe: Up to 4 years